3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
10
Pancreatic Neoplasms
8
Colorectal Neoplasms
8
Rectal Neoplasms
7
Neoplasm Metastasis
4
Colorectal Cancer Metastatic
4
Stomach Neoplasms
3
Ovarian Neoplasms
3
Colonic Neoplasms
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Gallbladder Neoplasms
2
Carcinoma, Merkel Cell
2
Biliary Tract Neoplasms
2
Zollinger-Ellison Syndrome
1
Vipoma
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Somatostatinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Non functioning pancreatic endocrine tumor
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Multiple Endocrine Neoplasia Type 2b
1
Multiple Endocrine Neoplasia Type 2a
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
Exercise
8
High-Intensity Interval Training
2
Resistance Training
1
Rehabilitation
1
Range of Motion, Articular
1
Oxaliplatin
1
Nutrition Assessment
1
Leucovorin
1
Hand Strength
1
Fluorouracil
1
Educational Status
1
Communication Devices for People with Disabilities
1
Cognitive Behavioral Therapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Motor Activity
×
Capecitabine
×
Clear all
NCT04488159
2024-09-20
iMAGINE
Medical University of Vienna
Phase 3
Withdrawn